Federated Hermes’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-121
| Closed | -$7K | – | 2213 |
|
|
2021
Q3 | $7K | Buy |
+121
| New | +$7K | ﹤0.01% | 2016 |
|
|
2021
Q1 | – | Sell |
-114
| Closed | -$2K | – | 2242 |
|
|
2020
Q4 | $2K | Buy |
114
+68
| +148% | +$1.19K | ﹤0.01% | 2117 |
|
|
2020
Q3 | $1K | Buy |
+46
| New | +$1K | ﹤0.01% | 2142 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$1K | – | 2205 |
|
|
2018
Q1 | $1K | Sell |
1
-6,054
| -100% | -$6.05M | ﹤0.01% | 2090 |
|
|
2017
Q4 | $258K | Sell |
6,055
-564
| -9% | -$24K | ﹤0.01% | 1475 |
|
|
2017
Q3 | $284K | Sell |
6,619
-4,021
| -38% | -$173K | ﹤0.01% | 1449 |
|
|
2017
Q2 | $394K | Sell |
10,640
-27,820
| -72% | -$1.03M | ﹤0.01% | 1423 |
|
|
2017
Q1 | $2.08M | Buy |
38,460
+3,211
| +9% | +$174K | 0.01% | 892 |
|
|
2016
Q4 | $1.87M | Buy |
35,249
+5,091
| +17% | +$270K | 0.01% | 892 |
|
|
2016
Q3 | $1.83M | Buy |
30,158
+4,164
| +16% | +$252K | 0.01% | 884 |
|
|
2016
Q2 | $1.71M | Buy |
+25,994
| New | +$1.71M | 0.01% | 904 |
|
|
2015
Q4 | – | Sell |
-7
| Closed | -$1K | – | 2094 |
|
|
2015
Q3 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 1892 |
|